Hunan ProMab Biotechnologies

ProMab Biotechnologies is a biotechnology company and contract research organization (CRO) specializing in antibody development and cell therapy. The company leverages its proprietary platforms to develop a diverse pipeline of Chimeric Antigen Receptor T-cell (CAR-T) therapies targeting both hematological malignancies and solid tumors. In addition to its internal drug discovery efforts, ProMab provides comprehensive services including custom antibody production, hybridoma development, and CAR-T validation to global pharmaceutical and academic partners. With facilities in both the United States and China, the company is positioned as a key player in the advancement of next-generation immunotherapy.